Biocytogen
Sujata Nerle is a seasoned professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Senior Business Development Manager at Biocytogen since January 2023, prior roles include positions at Nodes Advisors AG and Palleon Pharmaceuticals, where responsibilities encompassed research and leadership in immuno-oncology drug discovery. Sujata has also held various scientific roles at Rubius Therapeutics, ARIAD Pharmaceuticals, and Constellation Pharmaceuticals, contributing to significant advancements in drug development. Educational qualifications include an MBA in Entrepreneurship from the Manning School of Business at UMass Lowell, a Master's in Biotechnology from Texas Tech University, and a Bachelor's in Engineering from Shivaji University.
Biocytogen
2 followers
Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for antibody drug discovery, Biocytogen offers animal model generation, antibody fully human-mouse (RenMab mouse), therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO, and regulatory affairs support.